https://hdl.handle.net/10216/26780 2026-08-07T12:44:34Z 2026-08-07T12:44:34Z https://hdl.handle.net/10216/118854 2025-01-24T07:21:18Z 2016-01-01T00:00:00Z

Title: Use of polymyxin as an antidote for intoxications by amatoxins

2016-01-01T00:00:00Z https://hdl.handle.net/10216/111410 2022-10-13T11:19:43Z 2017-06-01T00:00:00Z

Title: OLIVE POMACE PRODUCTS, METHOD OF PRODUCTION AND THEIR USES

2017-06-01T00:00:00Z https://hdl.handle.net/10216/81189 2022-10-12T09:18:23Z 2009-01-01T00:00:00Z

Title: Patente US 20090081796 A1

2009-01-01T00:00:00Z https://hdl.handle.net/10216/80637 2022-10-19T09:33:58Z 2014-01-01T00:00:00Z

Title: TRYPTOPHANOL-DERIVED OXAZOLOISOINDOLINONES: SMALL-MOLECULE P53 ACTIVATORS Abstract: The present application discloses novel family of Tryptophanol-Derived Oxazoloisoindolinones for use in the treatment of p53 associated conditions, such as cancer. These compounds are p53 activators and may be used in pharmaceutical compositions, alone or in combination with other chemoterapeutic agents.

2014-01-01T00:00:00Z https://hdl.handle.net/10216/84923 2022-10-15T14:20:42Z 2008-01-01T00:00:00Z

Title: PATENTE DE INVENÇÃO NACIONAL Nº 103547

2008-01-01T00:00:00Z https://hdl.handle.net/10216/111417 2022-10-13T11:19:35Z 2016-12-01T00:00:00Z

Title: PROCESSO DE OBTENÇÃO DE EXTRATO BIOATIVO DAS FOLHAS DE AZADIRACHTA INDICA POR EXTRAÇÃO COM LÍQUIDOS PRESSURIZADOS E PRODUTO OBTIDO

2016-12-01T00:00:00Z https://hdl.handle.net/10216/111416 2022-10-13T14:39:30Z 2017-11-01T00:00:00Z

Title: PRODUTO DERIVADO DAS FOLHAS DE AZADIRACHTA INDICA COM EFEITO ANTIPROLIFERATIVO CONTRA AS CÉLULAS LINFOBLÁSTICAS HUMANAS

2017-11-01T00:00:00Z https://hdl.handle.net/10216/127285 2022-10-14T15:42:57Z 2018-12-14T00:00:00Z

Title: SPRELIVE - Foodstuff composition, process and uses thereof

2018-12-14T00:00:00Z https://hdl.handle.net/10216/80650 2022-10-17T14:52:58Z 2013-01-01T00:00:00Z

Title: Inibidores da interação p53-mdm2 Description: A presente invenção descreve composto de fórmula geral 1, (Fórmula 1), seus sais ou ésteres, no tratamento de doenças que são influenciadas positivamente pela inibição da interação p53-MDM2 ou p53-MDMX, em particular para o tratamento de neoplasias, de preferência no tratamento do cancro, nomeadamente do cancro da mama, colo-rectal, próstata, rim, pulmão, melanoma, osteossarcoma ou nefroma embrionário, entre outros.

2013-01-01T00:00:00Z https://hdl.handle.net/10216/111412 2019-06-05T15:58:19Z 2016-06-01T00:00:00Z

Title: OLIVE POMACE PRODUCTS, METHOD OF PRODUCTION AND THEIR USES

2016-06-01T00:00:00Z https://hdl.handle.net/10216/111414 2019-06-05T15:58:23Z 2017-12-01T00:00:00Z

Title: SPREADABLE FOOD COMPOSITION, PROCESS AND USES THEREOF

2017-12-01T00:00:00Z